Related Experiment Videos
Parathyroidectomy for hyperparathyroidism in maintenance dialysis patients
Scandinavian Journal of Urology and Nephrology
|January 1, 1983
Summary
Parathyroidectomy improved symptoms in most dialysis patients with severe bone disease. However, current treatments for hyperparathyroidism in these patients remain suboptimal, indicating a need for better therapeutic strategies.
Area of Science:
- Nephrology
- Endocrinology
- Surgical Pathology
Background:
- Secondary hyperparathyroidism is a common complication in patients with end-stage renal disease (ESRD) on maintenance dialysis.
- This condition is characterized by significant bone disease, hypercalcemia, and elevated parathyroid hormone (PTH) levels, often requiring surgical intervention.
Observation:
- A 5-year study evaluated 11 dialysis patients who underwent parathyroidectomy for severe symptomatic bone disease.
- Patients presented with long-term dialysis, severe hypercalcemia, elevated alkaline phosphatase, markedly increased serum immunoreactive PTH, and radiographic bone abnormalities, including metastatic calcifications and fractures.
Findings:
- Most patients experienced subjective and objective improvements post-parathyroidectomy, suggesting the procedure's indications were appropriate.
- Total parathyroidectomy, with or without autotransplantation, led to symptom relief in the majority, though a minority became completely symptom-free.
- Current management strategies for tertiary hyperparathyroidism in dialysis patients are considered suboptimal.
Implications:
- Total parathyroidectomy appears to be an acceptable surgical option for managing severe secondary hyperparathyroidism in patients undergoing chronic dialysis.
- Further research is needed to develop more effective and comprehensive treatment approaches for this complex patient population.